{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:16:40Z","timestamp":1788355000036,"version":"build-2803163510"},"reference-count":139,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Pancreatic cancer-associated cachexia (CAC) is a complex, multifactorial and multi-organ metabolic syndrome affecting approximately 80% of patients with pancreatic ductal adenocarcinoma (PDAC). Recent epidemiological data show that cachexia is a primary cause of mortality in PDAC, directly accounting for approximately 30% of cancer-related deaths and significantly limiting the tolerability of cancer therapy and is associated with adverse effects of treatment. It is defined by systemic weight loss, skeletal muscle atrophy (sarcopenia), and adipose tissue depletion, often driven by systemic inflammation and metabolic dysregulation. Methods: The literature was searched in PubMed and Scopus using combinations of keywords. The search covers the literature between 2016 and 2026, but papers before this period were also included because of their historical importance. Studies with higher evidential value, such as prospective studies, randomized controlled trials, and meta-analyses, were prioritized and emphasized in our analysis. Results: CAC in PC arises from a systemic inflammatory response driven by tumor\u2013host interactions and the release of pro-inflammatory mediators, such as growth differentiation factor 15 (GDF-15) and parathyroid hormone-related protein (PTHrP), which promotes anorexia and weight loss. The most commonly used diagnostic criteria include unintentional weight loss of more than 5% of body mass within 6 months, a body mass index (BMI) below 20 kg\/m2, or weight loss greater than 2% in the presence of sarcopenia. Emerging evidence supports the use of AI-based body composition analysis and novel biomarkers, including GDF-15 levels, to improve the detection and monitoring of cachexia. This review highlights that, despite the absence of pharmacological agents specifically approved for CAC in the United States and Europe, current guidelines recommend multimodal supportive care, including low-dose olanzapine, nutritional support, and exercise-based interventions. Furthermore, we identify recent phase 2 trials targeting the GDF-15 pathway, such as the GDF-15 inhibitor ponsegromab, which have demonstrated significant improvements in body weight and physical activity, suggesting a potential breakthrough in targeted therapies for CAC. Conclusions: CAC in PDAC represents a critical unmet medical need in oncology. It manifests as a lethal systemic pathology that demands early identification and targeted personalized pharmacological and nutritional interventions. Early diagnosis and targeted intervention represent promising strategies for improving survival and quality of life in this high-risk patient population.<\/jats:p>","DOI":"10.3390\/cancers18071060","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:07:13Z","timestamp":1774433233000},"page":"1060","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pathogenesis, Diagnostic Pathways, and New Therapeutic and Nutritional Strategies for Pancreatic Cancer-Associated Cachexia"],"prefix":"10.3390","volume":"18","author":[{"given":"Wiktoria","family":"Klus","sequence":"first","affiliation":[{"name":"Warsaw Genomics S.A., 02-089 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagoda","family":"Ossowska","sequence":"additional","affiliation":[{"name":"Warsaw Genomics S.A., 02-089 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kowalcze","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Health Sciences, Institute of Health Sciences, University of Siedlce, 08-110 Siedlce, Poland"},{"name":"Sirene Medical Clinic, 02-796 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kiliszczyk","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Clinic, Damian Medical Center, 02-674 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-1509","authenticated-orcid":false,"given":"Agnieszka","family":"Paziewska","sequence":"additional","affiliation":[{"name":"Warsaw Genomics S.A., 02-089 Warsaw, Poland"},{"name":"Faculty of Medical and Health Sciences, Institute of Health Sciences, University of Siedlce, 08-110 Siedlce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: A systemic consequence of progressive, unresolved disease","volume":"186","author":"Ferrer","year":"2023","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","article-title":"The interplay of immunology and cachexia in infection and cancer","volume":"22","author":"Baazim","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fonseca, G.W.P.D., Farkas, J., Dora, E., von Haehling, S., and Lainscak, M. (2020). Cancer Cachexia and Related Metabolic Dysfunction. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072321"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/jcsm.13435","article-title":"Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design","volume":"15","author":"Groarke","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the Treatment of Cancer Cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_6","first-page":"CD010804","article-title":"Exercise for cancer cachexia in adults","volume":"3","author":"Grande","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Oneda, E., Manno, A., Noventa, S., Libertini, M., Cherri, S., and Zaniboni, A. (2025). Role of diet, physical activity and new drugs in the primary management of cancer cachexia in gastrointestinal tumors\u2014A comprehensive review. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1600425"},{"key":"ref_8","first-page":"19","article-title":"Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma","volume":"6","author":"Permuth","year":"2025","journal-title":"Res. Sq."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yoon, S.L., Grundmann, O., Rogers, S., Schlaeger, J.M., Han, B., Agyare, E., and Wilkie, D.J. (2025). Cachexia in Pancreatic Cancer: New Insights to Impact Quality of Life and Survival. Nutrients, 17.","DOI":"10.3390\/nu17193064"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"C467","DOI":"10.1152\/ajpcell.00421.2025","article-title":"Ablation of tumor-derived IGFBP-3 attenuates cancer-associated skeletal muscle wasting in murine pancreatic cancer","volume":"330","author":"Sechrist","year":"2026","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.hlife.2025.05.002","article-title":"Pancreatic cancer cachexia: A systemic consequence of multi-organ interactions","volume":"3","author":"Xiao","year":"2025","journal-title":"hLife"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/1078-0432.CCR-23-1631","article-title":"A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia","volume":"30","author":"Crawford","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wiggs, M.P., Beaudry, A.G., and Law, M.L. (2022). Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors. Cells, 11.","DOI":"10.3390\/cells11121931"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ajpath.2024.06.008","article-title":"Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy Phenotype","volume":"194","author":"Ogilvie","year":"2024","journal-title":"Am. J. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.18632\/aging.205652","article-title":"Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients","volume":"16","author":"Yu","year":"2024","journal-title":"Aging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/joim.13671","article-title":"Underutilization of pancreatic enzyme replacement therapy in pancreatic cancer and chronic pancreatitis","volume":"294","author":"Kumar","year":"2023","journal-title":"J. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eadm8857","DOI":"10.1126\/science.adm8857","article-title":"A neuroimmune circuit mediates cancer cachexia-associated apathy","volume":"388","author":"Zhu","year":"2025","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13539-014-0142-1","article-title":"Psychosocial impact of cancer cachexia","volume":"5","author":"Hopkinson","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: Molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.21873\/anticanres.16188","article-title":"The Latest Treatments for Cancer Cachexia: An Overview","volume":"43","author":"Watanabe","year":"2023","journal-title":"Anticancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jcsm.12699","article-title":"Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting","volume":"12","author":"Cole","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Olumoyin, K.D., Park, M., Davis, E.W., Permuth, J.B., and Rejniak, K.A. (2025). Machine Learning-Based Identification of Blood Biomarkers that Distinguish Precachectic and Cachectic Patients with Pancreatic Ductal Adenocarcinoma. medRxiv.","DOI":"10.64898\/2025.12.23.25342866"},{"key":"ref_24","first-page":"4493","article-title":"Cancer anorexia-cachexia syndrome: Are neuropeptides the key?","volume":"59","author":"Inui","year":"1999","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/JOE-15-0170","article-title":"Molecular and neuroendocrine mechanisms of cancer cachexia","volume":"226","author":"Mendes","year":"2015","journal-title":"J. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmet.2020.10.023","article-title":"GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates","volume":"32","author":"Breen","year":"2020","journal-title":"Cell Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bbadis.2016.07.003","article-title":"Dexamethasone-induced muscular atrophy is mediated by functional expression of connexin-based hemichannels","volume":"1862","author":"Cea","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcsm.12307","article-title":"Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer","volume":"9","author":"Kays","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nm.3686","article-title":"Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development","volume":"20","author":"Mayers","year":"2014","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ncp.10588","article-title":"The Use of Visceral Proteins as Nutrition Markers: An ASPEN Position Paper","volume":"36","author":"Evans","year":"2021","journal-title":"Nutr. Clin. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/jcsm.13491","article-title":"Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series","volume":"15","author":"Yule","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Robinson, T.P., Hamidi, T., Counts, B., Guttridge, D.C., Ostrowski, M.C., Zimmers, T.A., and Koniaris, L.G. (2023). The impact of inflammation and acute phase activation in cancer cachexia. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1207746"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Keller, U. (2019). Nutritional Laboratory Markers in Malnutrition. J. Clin. Med., 8.","DOI":"10.3390\/jcm8060775"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Reber, E., Schonenberger, K.A., Vasiloglou, M.F., and Stanga, Z. (2021). Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.603936"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/0884533608321132","article-title":"The Mini Nutritional Assessment--its history, today\u2019s practice, and future perspectives","volume":"23","author":"Bauer","year":"2008","journal-title":"Nutr. Clin. Pract."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/CMAR.S294105","article-title":"Current Screening Methods for the Risk or Presence of Malnutrition in Cancer Patients","volume":"14","author":"Molfino","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7603\/s40681-015-0017-6","article-title":"The Malnutrition Universal Screening Tool (MUST) and a nutrition education program for high risk cancer patients: Strategies to improve dietary intake in cancer patients","volume":"5","author":"Chao","year":"2015","journal-title":"Biomedicine"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Seron-Arbeloa, C., Labarta-Monzon, L., Puzo-Foncillas, J., Mallor-Bonet, T., Lafita-Lopez, A., Bueno-Vidales, N., and Montoro-Huguet, M. (2022). Malnutrition Screening and Assessment. Nutrients, 14.","DOI":"10.20944\/preprints202205.0071.v1"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"w20517","DOI":"10.4414\/smw.2021.20517","article-title":"NRS-2002 components, nutritional score and severity of disease score, and their association with hospital length of stay and mortality","volume":"151","author":"Sahli","year":"2021","journal-title":"Swiss Med. Wkly."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nut.2016.07.015","article-title":"NUTRISCORE: A new nutritional screening tool for oncological outpatients","volume":"33","author":"Arribas","year":"2017","journal-title":"Nutrition"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2025.03.018","article-title":"The GLIM consensus approach to diagnosis of malnutrition: A 5-year update","volume":"49","author":"Cederholm","year":"2025","journal-title":"Clin. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wang, F., Wang, C., Zhang, L., and Li, X. (2025). Diagnostic consistency of GLIM criteria and PG-SGA for malnutrition in patients with pancreatic cancer. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1642171"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Zhang, L., Ding, Z., Zhao, Y., Cheng, Z., Hu, J., and Huo, L. (2025). Advances and challenges in nutritional screening and assessment for cancer patients: A comprehensive systematic review and future directions. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1688344"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.2147\/CMAR.S261585","article-title":"Cancer Cachexia: Definition, Staging, and Emerging Treatments","volume":"12","author":"Ni","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Huang, Y., Zhang, J., Ge, Y., Wang, C., Wang, X., and Zuo, J. (2026). Association between systemic inflammation biomarkers and cancer cachexia in patients with gastric cancer: A cross-sectional study. Front. Nutr., 13.","DOI":"10.3389\/fnut.2026.1737375"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Narasimhan, A., Shahda, S., Kays, J.K., Perkins, S.M., Cheng, L., Schloss, K.N.H., Schloss, D.E.I., Koniaris, L.G., and Zimmers, T.A. (2020). Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform. Cancers, 12.","DOI":"10.3390\/cancers12123787"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100438","DOI":"10.1016\/j.advnut.2025.100438","article-title":"Artificial Intelligence in the Management of Malnutrition in Cancer Patients: A Systematic Review","volume":"16","author":"Sguanci","year":"2025","journal-title":"Adv. Nutr."},{"key":"ref_50","first-page":"630","article-title":"Machine learning to identify precachexia and cachexia: A multicenter, retrospective cohort study","volume":"32","author":"Chen","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s43681-025-00837-y","article-title":"Hyper-selective explainability: An empirical case study of the utility of explainability in a clinical decision support system","volume":"6","author":"Duke","year":"2026","journal-title":"AI Ethics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.1093\/nutrit\/nuae094","article-title":"Skeletal Muscle Index-Based Cachexia Index as a Predictor of Prognosis in Patients with Cancer: A Meta-Analysis and Systematic Review","volume":"83","author":"Xu","year":"2025","journal-title":"Nutr. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ags3.12686","article-title":"Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma","volume":"7","author":"Shimagaki","year":"2023","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.21873\/anticanres.17509","article-title":"Prognostic Relationship Between the Cachexia Index and Osteopenia in Patients with Pancreatic Cancer","volume":"45","author":"Sakamoto","year":"2025","journal-title":"Anticancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Tsukagoshi, M., Araki, K., Kubo, N., Igarashi, T., Kawai, S., Hagiwara, K., Hoshino, K., Seki, T., Okuyama, T., and Fukushima, R. (2025). Impact of Preoperative Weight Loss on Prognosis in Patients with Pancreatic Cancer. Biomedicines, 13.","DOI":"10.3390\/biomedicines13071703"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clnu.2025.02.014","article-title":"Prognostic impact of preoperative cachexia in patients undergoing major hepatopancreatobiliary surgery for malignancy","volume":"47","author":"Fugane","year":"2025","journal-title":"Clin. Nutr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12957-024-03310-y","article-title":"Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: A updated systematic review and meta-analysis","volume":"22","author":"Liu","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"He, J., Li, J., Liu, J., and Liu, M. (2025). Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: An updated meta-analysis. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1656834"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13063-026-09467-z","article-title":"Multimodal Prehabilitation In Pancreatic cancer Patients undergoing surgery (PIPS): Study protocol for a randomized controlled trial","volume":"27","author":"Pecorelli","year":"2026","journal-title":"Trials"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12957-026-04202-z","article-title":"Post-surgery weight changes in pancreatic cancer: A prospective study on factors and survival impact","volume":"24","author":"Cui","year":"2026","journal-title":"World J. Surg. Oncol."},{"key":"ref_61","first-page":"e97007","article-title":"Enhanced Recovery After Surgery (ERAS) Protocols in Pancreatic Cancer Resections: Their Impact on Postoperative Morbidity","volume":"17","author":"Pandya","year":"2025","journal-title":"Cureus"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-D\u00edez, I., Andreu, Z., Hidalgo, M.R., Perpi\u00f1\u00e1-Cl\u00e9rigues, C., Fant\u00edn, L., Fernandez-Serra, A., de la Iglesia-Vaya, M., Lopez-Guerrero, J.A., and Garc\u00eda-Garc\u00eda, F. (2023). A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments. Cancers, 15.","DOI":"10.1101\/2023.03.31.535058"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.clnu.2025.08.029","article-title":"ESPEN guideline on clinical nutrition in surgery\u2014Update 2025","volume":"53","author":"Weimann","year":"2025","journal-title":"Clin. Nutr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.pan.2025.04.020","article-title":"International Association of Pancreatology Revised Guidelines on Acute Pancreatitis 2025: Supported and Endorsed by the American Pancreatic Association, European Pancreatic Club, Indian Pancreas Club, and Japan Pancreas Society","volume":"25","author":"Uc","year":"2025","journal-title":"Pancreatology"},{"key":"ref_65","first-page":"CD014792","article-title":"Postoperative nutritional support after pancreaticoduodenectomy in adults","volume":"3","author":"Robertson","year":"2025","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/02601060241290281","article-title":"Personalized nutrition after discharge for pancreatic surgery: A study protocol","volume":"31","author":"Pizzocaro","year":"2025","journal-title":"Nutr. Health"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Park, S., Choi, G.W., Lee, I., Seo, Y., Chae, Y.S., Yun, W.G., Han, Y., Jung, H.S., Kwon, W., and Park, J.S. (2025). Impact of Nutritional Changes on the Prognosis in Pancreatic Cancer Patients Underwent Curative Surgery After Neoadjuvant Chemotherapy. Nutrients, 17.","DOI":"10.3390\/nu17040647"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pan.2025.02.015","article-title":"Recommendations from the European guidelines for the diagnosis and therapy of pancreatic exocrine insufficiency","volume":"25","author":"Vujasinovic","year":"2025","journal-title":"Pancreatology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/082585979401000105","article-title":"A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia","volume":"10","author":"Nelson","year":"1994","journal-title":"J. Palliat. Care"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia","volume":"17","author":"Loprinzi","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11745-001-0726-4","article-title":"Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia","volume":"36","author":"Barber","year":"2001","journal-title":"Lipids"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia","volume":"24","author":"Fearon","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11912-016-0522-0","article-title":"Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)","volume":"18","author":"Crawford","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): Results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2169\/internalmedicine.3577-24","article-title":"Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with a Poor Performance Status","volume":"64","author":"Takeda","year":"2025","journal-title":"Intern. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s40266-025-01252-y","article-title":"Sarcopenia and Cachexia in Older Patients with Cancer: Pathophysiology, Diagnosis, Impact on Outcomes, and Management Strategies","volume":"42","author":"Papadopoulos","year":"2025","journal-title":"Drugs Aging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jpainsymman.2021.05.017","article-title":"Mirtazapine in Cancer-Associated Anorexia and Cachexia: A Double-Blind Placebo-Controlled Randomized Trial","volume":"62","author":"Hunter","year":"2021","journal-title":"J. Pain Symptom Manag."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-1819.2007.01778.x","article-title":"Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression","volume":"62","author":"Kim","year":"2008","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/rco2.54","article-title":"Lenalidomide in cancer cachexia: A randomized trial of an anticancer drug applied for anti-cachexia","volume":"5","author":"Blum","year":"2022","journal-title":"JCSM Rapid Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.31557\/APJCP.2022.23.7.2333","article-title":"A Double-Blind, Placebo-Controlled Randomized Phase IIa Study: Evaluating the Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Solid Cancer Patients","volume":"23","author":"Chaiworramukkul","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5425619","DOI":"10.1155\/2022\/5425619","article-title":"Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia)","volume":"2022","author":"Thambamroong","year":"2022","journal-title":"J. Nutr. Metab."},{"key":"ref_82","first-page":"9384","article-title":"Therapeutic applications of curcumin for patients with pancreatic cancer","volume":"20","author":"Kanai","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jjco\/hyae009","article-title":"Mirtazapine versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients: A randomized, double-blind trial","volume":"54","author":"Chowdhury","year":"2024","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10120-025-01637-3","article-title":"Effect of anamorelin on body weight in patients with gastric cancer-associated cachexia: An observational study","volume":"28","author":"Yanagimoto","year":"2025","journal-title":"Gastric Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.21873\/invivo.14161","article-title":"Anamorelin in Cancer Cachexia: Gut Microbiota Effects and CONUT Score as a Predictor of Response","volume":"39","author":"Boku","year":"2025","journal-title":"Vivo"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e13871","DOI":"10.1002\/jcsm.13871","article-title":"A Randomized Trial of Nutrition and Exercise Treatment in Patients with Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO)","volume":"16","author":"Mitsunaga","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"T\u0142ustochowicz, K., Krajewska, A., Kowalik, A., and Ma\u0142ecka-Wojciesko, E. (2025). Treatment Strategies for Chronic Pancreatitis (CP). Pharmaceuticals, 18.","DOI":"10.3390\/ph18030311"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"M\u0119kal, D., Sobocki, J., Badowska-Kozakiewicz, A., Sygit, K., Cipora, E., Bandurska, E., Czerw, A., and Depta\u0142a, A. (2023). Evaluation of Nutritional Status and the Impact of Nutritional Treatment in Patients with Pancreatic Cancer. Cancers, 15.","DOI":"10.3390\/cancers15153816"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1016\/j.clnu.2020.04.008","article-title":"Effect of a leucine-rich supplement in combination with nutrition and physical exercise in advanced cancer patients: A randomized controlled intervention trial","volume":"39","author":"Storck","year":"2020","journal-title":"Clin. Nutr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcsm.12201","article-title":"A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer","volume":"8","author":"Solheim","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Nasrah, R., and Jagoe, R.T. (2026). The gut microbiome and dietary interventions in cancer cachexia. Curr. Opin. Clin. Nutr. Metab. Care.","DOI":"10.1097\/MCO.0000000000001211"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Tanaka, K., Nakamura, S., and Narimatsu, H. (2022). Nutritional Approach to Cancer Cachexia: A Proposal for Dietitians. Nutrients, 14.","DOI":"10.3390\/nu14020345"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcsm.12525","article-title":"Nutrition interventions to treat low muscle mass in cancer","volume":"11","author":"Prado","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/0973-029X.86670","article-title":"Cancer cachexia","volume":"15","author":"Dhanapal","year":"2011","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/bjc.1987.149","article-title":"Reduction of weight loss and tumour size in a cachexia model by a high fat diet","volume":"56","author":"Tisdale","year":"1987","journal-title":"Br. J. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Mann, G., Mora, S., Madu, G., and Adegoke, O.A.J. (2021). Branched-chain Amino Acids: Catabolism in Skeletal Muscle and Implications for Muscle and Whole-body Metabolism. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.702826"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"de Castro, G.S., Andrade, M.F., Pinto, F.C.S., Faiad, J.Z., and Seelaender, M. (2021). Omega-3 Fatty Acid Supplementation and Its Impact on Systemic Inflammation and Body Weight in Patients With Cancer Cachexia-A Systematic Review and Meta-Analysis. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.797513"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"250S","DOI":"10.1093\/jn\/136.1.250S","article-title":"Branched-chain amino acid catabolism in exercise and liver disease","volume":"136","author":"Shimomura","year":"2006","journal-title":"J. Nutr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2068S","DOI":"10.1093\/jn\/133.6.2068S","article-title":"Interorgan amino acid transport and its regulation","volume":"133","author":"Brosnan","year":"2003","journal-title":"J. Nutr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clnesp.2023.12.150","article-title":"A dose-response meta-analysis of randomized clinical trials investigating the effects of omega-3 supplementation on body weight in patients with cancer cachexia","volume":"59","author":"Hosseini","year":"2024","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clnu.2015.04.013","article-title":"A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer","volume":"35","author":"Mocellin","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO Guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12032-021-01625-4","article-title":"Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary tract cancer or pancreatic cancer during chemotherapy: A case-control study","volume":"39","author":"Abe","year":"2022","journal-title":"Med. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Emanuel, A., Krampitz, J., Rosenberger, F., Kind, S., and R\u00f6tzer, I. (2022). Nutritional Interventions in Pancreatic Cancer: A Systematic Review. Cancers, 14.","DOI":"10.3390\/cancers14092212"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.clnu.2022.07.039","article-title":"Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: A systematic review of randomised controlled trials","volume":"41","author":"Miller","year":"2022","journal-title":"Clin. Nutr."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/MPA.0000000000001829","article-title":"Diet and Exercise Interventions in Patients with Pancreatic Cancer: A Scoping Review","volume":"50","author":"Kasvis","year":"2021","journal-title":"Pancreas"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/01635581.2020.1871495","article-title":"Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer","volume":"74","author":"Ueno","year":"2022","journal-title":"Nutr. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Pires, L.B.C., Salaroli, L.B., Podesta, O.P.G., Haraguchi, F.K., and Lopes-J\u00fanior, L.C. (2024). Omega-3 Supplementation and Nutritional Status in Patients with Pancreatic Neoplasms: A Systematic Review. Nutrients, 16.","DOI":"10.3390\/nu16234036"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ueg2.12674","article-title":"European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations","volume":"13","author":"Vujasinovic","year":"2025","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"100541","DOI":"10.1016\/j.gastha.2024.08.019","article-title":"Impact of Order Set on Exocrine Pancreatic Insufficiency in Chronic Pancreatitis, Pancreatic Cancer, and Pancreatic Resection","volume":"4","author":"Ladna","year":"2025","journal-title":"Gastro Hep Adv."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1136\/bmjspcare-2019-002153","article-title":"Enzyme replacement in advanced pancreatic cancer: Patient perceptions","volume":"13","author":"Landers","year":"2023","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"oyaf014","DOI":"10.1093\/oncolo\/oyaf014","article-title":"Pancreatic enzyme replacement therapy in advanced adenocarcinoma of the pancreas improved overall survival: A retrospective, single institution study","volume":"30","author":"Picozzi","year":"2025","journal-title":"Oncologist"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e793","DOI":"10.1093\/oncolo\/oyad101","article-title":"Pancreatic Enzyme Replacement and Nutritional Support with nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer","volume":"28","author":"Giordano","year":"2023","journal-title":"Oncologist"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"znad369","DOI":"10.1093\/bjs\/znad369","article-title":"Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: Meta-analysis","volume":"111","author":"Hall","year":"2024","journal-title":"Br. J. Surg."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Halle-Smith, J.M., Hall, L.A., Powell-Brett, S.F., Merali, N., Frampton, A.E., Beggs, A.D., Moss, P., and Roberts, K.J. (2023). Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and Therapies?. Cancers, 15.","DOI":"10.3390\/cancers15215140"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12934-020-01482-2","article-title":"Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency","volume":"19","author":"Ritz","year":"2020","journal-title":"Microb. Cell Fact."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1631\/jzus.B2300070","article-title":"Impacts of pancreatic exocrine insufficiency on gut microbiota","volume":"25","author":"Guo","year":"2024","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_118","unstructured":"The RICOCHET Study Group on behalf of the West Midlands Research Collaborative (2021). Pancreatic enzyme replacement therapy in patients with pancreatic cancer: A national prospective study. Pancreatology, 21, 1127\u20131134."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1002\/ncp.11129","article-title":"Fat malabsorption in pancreatic cancer: Pathophysiology and management","volume":"39","author":"Murray","year":"2024","journal-title":"Nutr. Clin. Pract."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Viana, L.R., Canevarolo, R., Luiz, A.C., Soares, R.F., Lubaczeuski, C., Zeri, A.C., and Gomes-Marcondes, M.C. (2016). Leucine-rich diet alters the 1H-NMR based metabolomic profile without changing the Walker-256 tumour mass in rats. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2811-2"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Braha, A., Albai, A., Timar, B., Negru, \u0218., Sorin, S., Roman, D., and Popovici, D. (2022). Nutritional Interventions to Improve Cachexia Outcomes in Cancer-A Systematic Review. Medicina, 58.","DOI":"10.3390\/medicina58070966"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41430-024-01433-9","article-title":"Malnutrition, sarcopenia and cachexia: Exploring prevalence, overlap, and perceptions in older adults with cancer","volume":"78","author":"Bullock","year":"2024","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jcsm.12402","article-title":"Orphan disease status of cancer cachexia in the USA and in the European Union: A systematic review","volume":"10","author":"Anker","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12943-025-02513-5","article-title":"Gut microbiota reshaping the pancreatic cancer immune microenvironment: New avenues for immunotherapy","volume":"24","author":"Zheng","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4251\/wjgo.v14.i7.1218","article-title":"Gut microbiome and pancreatic cancer cachexia: An evolving relationship","volume":"14","author":"Hendifar","year":"2022","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41416-025-03324-7","article-title":"Intratumoral microbiome and pancreatic cancer: An enabling hallmark and path to novel treatments?","volume":"134","author":"Carstensen","year":"2025","journal-title":"Br. J. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2025.05.004","article-title":"The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC","volume":"113","author":"Peduzzi","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trecan.2024.11.003","article-title":"Short-chain fatty acids and cancer","volume":"11","author":"Li","year":"2025","journal-title":"Trends Cancer"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcancer.2025.03.002","article-title":"The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancer","volume":"112","author":"Daniel","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12943-025-02458-9","article-title":"Microbiome-metabolome interplay in pancreatic cancer progression: Insights from multi-omics analysis","volume":"24","author":"Luo","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Kim, B., Oh, S., Yang, S., Ahn, J., Jung, K., Lee, J.C., Hwang, J.H., Shin, C.M., Lee, H.J., and Lee, H.S. (2025). Distinct microbiome composition and reduced interactions in patients with pancreatic cancer. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1555479"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2470372","DOI":"10.1080\/19490976.2025.2470372","article-title":"Upregulation of Lactobacillus spp. in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects","volume":"17","author":"Liang","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/jcsm.12804","article-title":"Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients","volume":"12","author":"Ubachs","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Zhao, L., Peng, S., Ge, M., Xing, B., Zhao, X., Yang, T., Yu, S., Zhang, C., Liu, J., and Miao, Z. (2025). Gut-to-tumor translocation of multidrug-resistant. Front. Cell Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1694479"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41575-025-01119-y","article-title":"Multifaceted effects of the microbiome in pancreatic cancer: From association to modulation","volume":"22","author":"Thomas","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Tavanaeian, S., Feizabadi, M.M., Falsafi, S., Aghdaei, H.A., and Houri, H. (2025). Oral and fecal microbiome alterations in pancreatic cancer: Insights into potential diagnostic biomarkers. BMC Microbiol., 25.","DOI":"10.1186\/s12866-025-04344-2"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-012-0096-0","article-title":"Cancer cachexia prevention via physical exercise: Molecular mechanisms","volume":"4","author":"Gould","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"100335","DOI":"10.1016\/j.apjon.2023.100335","article-title":"Exercise-based interventions for cancer cachexia: A systematic review of randomised and non-randomised controlled trials","volume":"10","author":"Cheung","year":"2023","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"100748","DOI":"10.1016\/j.apjon.2025.100748","article-title":"The role of aerobic and resistance exercise for cancer cachexia management\u2014A systematic scoping review","volume":"12","author":"Peyrachon","year":"2025","journal-title":"Asia Pac. J. Oncol. Nurs."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/7\/1060\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:27:04Z","timestamp":1774434424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/7\/1060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":139,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["cancers18071060"],"URL":"https:\/\/doi.org\/10.3390\/cancers18071060","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}